Feature
July 10, 2012 — A study led by researchers at the University of California, San Francisco (UCSF) and the Group Health Research Institute (GHRI) shows that medical imaging is increasing even in health maintenance organization systems (HMOs), which don’t have a financial incentive to conduct them.
July 10, 2012
News
July 10, 2012 — Based on its recent analysis of workflow solutions for the computed tomography (CT) imaging market, Frost & Sullivan recognized Siemens Healthcare with the 2012 North American Frost & Sullivan Award for Customer Value Enhancement.
July 10, 2012
News
July 10, 2012 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology (ACR) Appropriateness Criteria. These continually updated criteria are a national standard, developed by expert panels of physicians from many different medical specialties.
July 10, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology
July 9, 2012 — r4 Vascular Inc. announced clearance from the U.S. Food and Drug Administration (FDA) to market the Vector percutaneous transluminal angioplasty (PTA) balloon catheters in 28 sizes.
July 09, 2012
News
July 9, 2012 — Miracor Medical Systems GmbH announced that the first three ST segment elevation myocardial infarction (STEMI) patients enrolled in its “Prepare RAMSES” nonrandomized safety and feasibility study of 40 patients have been successfully treated using PICSO (pressure-controlled intermittent coronary sinus occlusion) for 90 minutes following primary PCI (percutaneous coronary intervention, or angioplasty) of the left anterior descendens (LAD) coronary artery.
July 09, 2012News
July 9, 2012 — Cardionovum GmbH announced it has initiated in vivo testing of its second drug-eluting balloon (DEB) Restore. The company is currently marketing a line of CE-marked paclitaxel-coated DEBs for coronary (Primus) and peripheral (Legflow) applications. Cardionovum is featured in the most recent issue of IN VIVO magazine.
July 09, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
July 9, 2012 — Endosystems Inc., a medical device company developing technology for endovascular aneurysm repair (EVAR), announced closing on $25 million of equity financing. Synergy Life Science Partners, a new investor, led the round and was joined by existing investors US Venture Partners and Longitude Capital Management. Mudit K. Jain, Ph.D., partner at Synergy Life Science Partners, will join the company’s board of directors.
July 09, 2012
News
July 9, 2012 — A new report issued in June by the American College of Cardiology (ACC) and developed in collaboration with 10 other professional societies provides detailed criteria to help clinicians maximize the appropriate use of certain noninvasive vascular tests when caring for patients with suspected or known non-coronary arterial disorders.
July 09, 2012News
July 9, 2012 — GE Healthcare unveiled in June the GE Blueprint for low dose, a comprehensive program that helps healthcare providers integrate CT (computed tomography) technologies, education and process improvements, and data analysis to reduce patient radiation dose from CT by up to 50 percent.
July 09, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
July 9, 2012 — Burlington Medical Supplies, a radiation protection and X-ray medical supply company, now offers no fog lenses. These lead glasses are the latest in technology for healthcare professionals who work in scatter radiation environments, such as doctors, nurses and technologists.
July 09, 2012News
July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human (FIH) clinicals have been confirmed by Doppler and ultrasound evaluation. The evaluation confirmed normal vessel healing, with complete absorption of the FastSeal sealing element.
July 06, 2012News
July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S. Food and Drug Administration (FDA) approval for the Watchman Left Atrial Appendage (LAA) Closure device.
July 06, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | Cardiovascular Ultrasound
Three big trends were seen in cardiovascular ultrasound during the American Society of Echocardiography (ASE) 2012 ...
July 06, 2012
Feature | Dave Fornell
With last year’s U.S. Food and Drug Administration approval of transcatheter aortic valve replacement (TAVR) and increasingly complex cath lab and hybrid operating room (OR) interventions, ultrasound is playing an increasing role in procedural guidance. This is especially true for use of 3-D/4-D transesophageal echo (TEE), which enables the more precise surgical-view visualization required for structural heart procedures, such as atrial septal defect (ASD) occluder and MitraClip deployments. These repairs would otherwise be extremely difficult to accomplish using fluoroscopy alone.
July 06, 2012
News
July 5, 2012 — Avinger Inc., a medical device manufacturer of multifunctional catheters, announced in June that it has successfully completed enrollment in its CONNECT II global clinical trial.
July 05, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now